Research Articles | Page 9 | Aplastic Anemia and MDS International Foundation (AAMDSIF) Return to top.

Research Articles

Compiled for your convenience are articles on bone marrow failure research and treatment from the world’s major journals on hematology / oncology.

Article Title Original Publication Date Journal Bone Marrow Disease
Machine learning demonstrates that somatic mutations imprint invariant morphologic features in myelodysplastic syndromes Sep 2020 Blood Myelodysplastic Syndromes (MDS)
SF3B1-mutant myelodysplastic syndrome as a distinct disease subtype - A Proposal of the International Working Group for the Prognosis of Myelodysplastic Syndromes (IWG-PM) Apr 2020 Blood Myelodysplastic Syndromes (MDS)
Newly revised 2023 MDS response criteria Apr 2023 Blood Myelodysplastic Syndromes (MDS)
Efficacy and Safety of Venetoclax Plus Azacitidine for Patients With Treatment-Naive High-Risk Myelodysplastic Syndromes Dec 2024 Blood Myelodysplastic Syndromes (MDS)
Consensus proposal for revised International Working Group 2023 response criteria for higher-risk myelodysplastic syndromes Apr 2023 Blood Myelodysplastic Syndromes (MDS)
TP53 mutations in myelodysplastic syndromes and secondary AML confer an immunosuppressive phenotype Jul 2020 Blood Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes (MDS)
Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes Sep 2024 Blood Myelodysplastic Syndromes (MDS)
T-cell dysfunctions in myelodysplastic syndromes Apr 2024 Blood Myelodysplastic Syndromes (MDS)
Secondary Myelodysplastic Syndrome and Leukemia in Acquired Aplastic Anemia and Paroxysmal Nocturnal Hemoglobinuria May 2020 Blood Aplastic Anemia, Myelodysplastic Syndromes (MDS), Paroxysmal Nocturnal Hemoglobinuria (PNH)
Germline DDX41 mutations define a significant entity within adult MDS/AML patients Sep 2019 Blood Myelodysplastic Syndromes (MDS)